Med Device Company Intersect ENT Raises Series D

Medical device company Intersect ENT has raised a $30 million Series D round of funding that was led by new investor Norwest Venture Partners. Also participating in the round were existing investors Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic. The company, which develops therapies for ear, nose and throat surgeons, previously raised $30 million in known funding.

25 February 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail